Matches in Wikidata for { <http://www.wikidata.org/entity/Q73132177> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q73132177 description "article scientifique publié en 1997" @default.
- Q73132177 description "artículu científicu espublizáu en marzu de 1997" @default.
- Q73132177 description "im März 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73132177 description "scientific article published on 01 March 1997" @default.
- Q73132177 description "wetenschappelijk artikel" @default.
- Q73132177 description "наукова стаття, опублікована в березні 1997" @default.
- Q73132177 name "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 name "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 type Item @default.
- Q73132177 label "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 label "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 prefLabel "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 prefLabel "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 P1433 Q73132177-5489541F-484A-4949-A477-E10B04643EC4 @default.
- Q73132177 P1476 Q73132177-4B817CE2-DF05-47EB-A202-B47EA101FE0D @default.
- Q73132177 P2093 Q73132177-0977A7C1-C10B-47AB-BF60-AA77CDEBEE1A @default.
- Q73132177 P2093 Q73132177-11E774B9-2362-4945-BBC8-4B33F1CF59E3 @default.
- Q73132177 P2093 Q73132177-18639F16-8FA8-447C-87EF-A05AC7A7AAE9 @default.
- Q73132177 P2093 Q73132177-1A56FE4A-BA2B-4116-8177-FD35DF9D5852 @default.
- Q73132177 P2093 Q73132177-3AE7343C-01E6-48C5-91B0-5977529F1EEF @default.
- Q73132177 P2093 Q73132177-813E9192-0327-4B4A-80BB-33F59ABDAACA @default.
- Q73132177 P2093 Q73132177-82EC14D8-C77A-47F5-9585-0A9975AD7172 @default.
- Q73132177 P2093 Q73132177-8596EFC5-5C11-4DB9-BBFF-617E49CF39E3 @default.
- Q73132177 P2093 Q73132177-9C700F41-1344-4E8D-89A6-9A00662D7930 @default.
- Q73132177 P2093 Q73132177-A1901B45-27D1-43E6-BEE6-94FBD131EF04 @default.
- Q73132177 P2093 Q73132177-E41E028F-9624-47F2-A122-4A10909F8461 @default.
- Q73132177 P304 Q73132177-D222D38C-3B1D-4309-A265-80B3DFC08F4B @default.
- Q73132177 P31 Q73132177-FC7DF56D-EAAB-46A8-B7B8-764D32AB882F @default.
- Q73132177 P356 Q73132177-DB35C384-E65F-4BEC-87DE-C6CE11563BBC @default.
- Q73132177 P407 Q73132177-B9E9F4D3-3C43-4E4C-A52A-377FD177BEA6 @default.
- Q73132177 P433 Q73132177-44A0749E-D2B8-4659-98C6-F7D43EB7567B @default.
- Q73132177 P478 Q73132177-B0502038-2FF7-45D1-BCE7-37D5E869E01B @default.
- Q73132177 P577 Q73132177-63280D25-2CC9-494F-8372-D93B80952A07 @default.
- Q73132177 P698 Q73132177-2344A0DE-4A70-4ADA-80F0-A98C7B64714E @default.
- Q73132177 P921 Q73132177-40F78BBB-E7F3-48C5-9FB6-ACC8A36BDBBC @default.
- Q73132177 P921 Q73132177-A0611F29-51A3-47B8-B031-8C0D2670329C @default.
- Q73132177 P356 JCO.1997.15.3.1052 @default.
- Q73132177 P698 9060545 @default.
- Q73132177 P1433 Q400292 @default.
- Q73132177 P1476 "Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma" @default.
- Q73132177 P2093 "C Dinarello" @default.
- Q73132177 P2093 "E G Trehu" @default.
- Q73132177 P2093 "J S Du Bois" @default.
- Q73132177 P2093 "J W Mier" @default.
- Q73132177 P2093 "K Kappler" @default.
- Q73132177 P2093 "L Ronayne" @default.
- Q73132177 P2093 "L Shapiro" @default.
- Q73132177 P2093 "M B Atkins" @default.
- Q73132177 P2093 "M Epstein" @default.
- Q73132177 P2093 "M Klempner" @default.
- Q73132177 P2093 "W Rand" @default.
- Q73132177 P304 "1052-1062" @default.
- Q73132177 P31 Q13442814 @default.
- Q73132177 P356 "10.1200/JCO.1997.15.3.1052" @default.
- Q73132177 P407 Q1860 @default.
- Q73132177 P433 "3" @default.
- Q73132177 P478 "15" @default.
- Q73132177 P577 "1997-03-01T00:00:00Z" @default.
- Q73132177 P698 "9060545" @default.
- Q73132177 P921 Q1164529 @default.
- Q73132177 P921 Q269829 @default.